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1. Introduction 
Many cardiologists have usually operated percutaneous coronary intervention (PCI) for coronary 
artery disease practically. Sometimes, complications following stent implantation rarely include 
thrombosis, rupture, sepsis and infected coronary aneurysm [Baddour, 2004; Berkalp, 1999]. 
Particularly, infected coronary aneurysm causes fatal outcome. In addition to contamination at 
the time of catheterization, there are other mechanisms how stents can become infected, 
including transient bacteremia from skin flora via access-site hematomas, pseudoaneurysms, 
delayed bleeding, prolonged arterial sheath insertion, and several procedures performed from 
the same access site over a short time period [Baddour, 2004]. Previous report demonstrated that 
18% of patients who underwent complex PCIs had detectable bacteremia [Ramsdale, 2004]. 
However, prophylactic antibiotics administarations are not conducted routinely prior to 
coronary stenting in the current PCI procedures, because the incident rate of stent infections was 
reported to be less than one in 10,000 cases [Myles, 2000].   
The drug-eluting stent (DES) era was ushered in with the first published human study by 
Sousa et al. in 2001, showing a nearly complete abolition of neointimal hyperplasia by use of 
sirolimus-eluting stent (SES) [Sousa, 2001]. The role of DES is very questionable, because of 
long term anticoagulant therapy, but in the patients with comorbidity (diabetes mellitus) DES 
are recommend. Despite the dramatic capacity of SES to reduce the restenosis rate after PCI, 
several SES-related problems have been raised [Ong & Serruys, 2005]; 1) the requirement of a 
prolonged dual anti-platelet regimen to avoid the risk of DES thrombosis [McFadden, 2004], 2) 
the occurrence of acquired late malapposition 3) the late formation of coronary artery 
aneurysm (SES having an antiproliferative action may be responsible for the delayed and 
inappropriate healing, which should lead to weakening of the arterial wall and delayed 
aneurysm formation) [Abreu, 2005; Degertekin, 2003], 4) a severe localized hypersensitivity 
consisting predominantly of T lymphocytes and eosinophils, which was caused by the metallic 
stent, polymer, or sirolimus [Virmani, 2004; Nebeker, 2005; Stabile, 2004].  
2. Case report 
A 70-year-old man with hypertension, type 2 diabetes mellitus, mild renal dysfunction and 
old cerebral infarction, was admitted to our hospital with sustained angina.  The patient 
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suffered an inferior wall ST-depression unstable angina that required immediate PCI with 
two SESs (Cypher®, Cordis Johnson & Johnson, Japan) in the proximal right coronary artery 
(RCA) (Figure 1). Satisfactory angiographic results were obtained with smooth luminal 
outline, and then the arterial sheath was removed (Figure 1). The patient had other 
significant stenosis lesions in the proximal left anterior descending artery (LAD) and the 
middle circumflex artery (LCX).  
 
 
Fig. 1. Right coronary artery angiogram performed during the initial procedure. 
Preangioplasty (left anterior oblique (LAO) view): the RCA was affected with severe 
stenosis in the proximal site (arrow) (A).  The RCA was opened and SESs was inserted (B). 
Satisfactory angiographic results were obtained with smooth luminal outline.  No contrast 
extravasation outside the vessel wall was noted on the image [Reproducted Kishida, 2007]. 
Next day after the procedure, this patient had fever without suppuration on the access site, 
and grew Staphylococcus aureus on repeat blood cultures. Despite exhaustive screenings for a 
potential source of the infection, no infectious focus was detected. The patient was treated 
with intravenous adapted antibiotics, however, remained poor.  
Three weeks after PCI, the patient had fever, convulsion and syncope attack with the 
torsades de pointes in ECG. The causes were considered due to trouble of the residual left 
coronary arteries (LCAs) lesions, and the patient was successfully implanted two SESs in the 
target LAD stenosis and a SES in the target LCX stenosis. The postprocedural course was 
uneventful, and the inflammatory sings were improved by the treatment with adapted 
antibiotics. 
Two months later, the patient has recurrence fever with eosinophilia and an inferolateral 
wall ST-depression angina. Coronary angiography revealed no obvious changes in the 
LCAs, but an occluded proximal RCA stent, a large aneurysm off the stent, and a fistula into 
the right ventricular chamber with rapid clearance (Figure 2). A 16-slice multidetector 
computed tomographic angiogram scan confirmed both an occluded proximal RCA, and the 
aneurysm (50x30 mm in size) forming fistula (10 mm in size) into right ventricle (Figure 3).  
The patient underwent a resection of the RCA stents and aneurysm, and a reconstruction of 
the right ventricular wall without coronary bypass grafting. Microscopic specimen from the 
resected aneurismal wall revealed an extensive inflammatory reaction with a predominance 
of neutrophils consisten with the micro-abscessn (Figure 4). The patient is doing well 5 years 
after operation [Kishida, 2007].  
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Fig. 2. Right coronary artery angiogram performed at the fever period 
Angiography of the RCA demonstrated occlusion of proximal stent site, an entry point to 
aneurysm, and the saccular aneurysm in the area of proximal stents and its coronary artery 
fistula originating from the RCA stents, with contrast spillage into the right ventricular 
chamber through the fistula. Rapid clearance of contrast was observed, with none in the 
pericardial space [Reproducted Kishida, 2007]. 
 
 
Fig. 3. The 16-slice multidetector computed tomographic angiogram disclosed huge RCA 
aneurysm (10x10 mm in diameter) and draining image into right ventricular chamber via 
fistula [Reproducted Kishida, 2007]. 
 
 
Fig. 4. Histopathology from pseudoaneurysm after surgical excision. Its histopathologic 
examination revealed marked inflammatory reaction with a predominance of neutrophils 
cocistent with an abscess. Hematoxylin and eosin staining. (original magnification, x200) 
[Reproducted Kishida, 2007]. 
RCA aneurysm 
RV 
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2.1 Comments for case report 
To date, there have been only 7 reported cases of infected drug-eluting stented coronary 
aneurysm, including our case [Kishida, 2007; Marcu, 2005; Alfonso, 2006; Singh, 2005; Jang, 
2007; Le, 2007; Furutado, 2011] (Table 1). In six cases Staphylococcus aureus and one 
Pseudomonas aeruginosa bacteremia was responsible for causing mycotic stent 
complications. Of these cases, there were two cases of an infected drug-eluting stented 
coronary aneurysm forming fistula to cardiac chamber. The mechanism of infection at the 
site of drug-eluting stenting is not well understood. Potential caused for drug-eluting 
coronary stent infections include local suppression of immune response and 
endothelialization which should lead to weakening of the arterial wall and delayed 
aneurysm formation [Degertekin, 2003]. The potential role of SES in locally blunting the 
innate response to bacterial agents may be considered. Formation of mycotic aneurismal 
fistula in our case may be partly accounted for by this mechanism. 
 
 
 
 
Table 1. Infected drug-eluting stented coronary aneurysm 
3. Conclusion 
Infections specificity, related to the use of intracoronary DESs, is exceedingly rare. However, 
stent infection should be considered in the differential diagnosis of patients presenting 
unexplained fever and relapsing bacteremia at any time following drug-eluting stenting.  
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In this book we examined a periprocedural complication of coronary angiography, and coronary intervention.
That includes related to cardiac catheterization and diagnostic coronary angiography, and those that occur as
a consequence of the specific equipment. However, improvements in devices, the use of stents, and
aggressive antiplatelet therapy have significantly reduced the incident of major periprocedural complications.
This book giving knowledge and experiences many of interventional cardiologists from all over the world, and
provide possibility to recognize new approach in this domain. Book gives lecture on how we image and how we
decide on what to treat, how to treat it, and then results of that treatment. They offer many answers to what we
have today and what we will have tomorrow.
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